Astellas and Dr. Jen Ashton launch "Cooler Moments" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves

PR Newswire

2024-12-05

"Cooler Moments" educates and empowers women in midlife to speak up for themselves and celebrate this natural change in their lives. NORTHBROOK, Ill., Dec. 5, 2024 /PRNewswire/ -- Astellas Pharma US, ...

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2489345456"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489345456\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2489345456?lang=zh_CN&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/mDzIeKJE_9jXg01gnDqnnQ--~B/aD0xODAwO3c9MjcwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/90cfe5e096dcfdc59723a8c260860bb5","is_english":true,"pubTime":"2024-12-05 21:49","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2489345456","market":"us","top_or_hot":-1,"title":"Astellas and Dr. Jen Ashton launch \"Cooler Moments\" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves","media":"PR Newswire","content":"<div>\n<p>\"Cooler Moments\" educates and empowers women in midlife to speak up for themselves and celebrate this natural change in their lives.\nNORTHBROOK, Ill., Dec. 5, 2024 /PRNewswire/ -- Astellas Pharma US, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/astellas-dr-jen-ashton-launch-134900879.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Astellas and Dr. Jen Ashton launch \"Cooler Moments\" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstellas and Dr. Jen Ashton launch \"Cooler Moments\" to Spotlight Menopausal Hot Flashes and Empower Women to Advocate for Themselves\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-05 21:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/astellas-dr-jen-ashton-launch-134900879.html><strong>PR Newswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>\"Cooler Moments\" educates and empowers women in midlife to speak up for themselves and celebrate this natural change in their lives.\nNORTHBROOK, Ill., Dec. 5, 2024 /PRNewswire/ -- Astellas Pharma US, ...</p>\n\n<a href=\"https://finance.yahoo.com/news/astellas-dr-jen-ashton-launch-134900879.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALPMF","symbol_name":"Astellas Pharma, Inc.","start_time":0,"source_url":"https://finance.yahoo.com/news/astellas-dr-jen-ashton-launch-134900879.html","article_id":"2489345456","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/mDzIeKJE_9jXg01gnDqnnQ--~B/aD0xODAwO3c9MjcwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/90cfe5e096dcfdc59723a8c260860bb5"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/astellas-dr-jen-ashton-launch-134900879.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2489345456","pubTimestamp":1733406540,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"\"Cooler Moments\" educates and empowers women in midlife to speak up for themselves and celebrate this natural change in their lives.Dr. Jen Ashton, Board-Certified OBGYN, Former Chief Medical Correspondent\"I'm honored to partner with Astellas to help inspire conversation about hot flashes and night sweats due to menopause and treatment options. Managing these symptoms is not one-size-fits-all, and women should feel comfortable having an open dialogue with their healthcare providers to create a plan that's right for them. As a doctor, I've seen how hot flashes due to menopause can significantly impact women, and I know how important it is women are counseled about all of their options, both hormonal and nonhormonal.2Many women and doctors alike may not know that there are nonhormonal treatment options such as VEOZAH available, especially for women who cannot or choose not to take hormon","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALPMF":"Astellas Pharma, Inc.","ALPMY":"Astellas Pharma, Inc.","EMPW.U":"Empower Ltd.","BK4007":"制药"},"translate_title":"安斯泰来(Astellas)和Jen Ashton博士推出“Cooler Moments”，聚焦更年期潮热，让女性能够为自己辩护","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALPMF":0.9,"ALPMY":0.9,"EMPW.U":1},"content_text":"\"Cooler Moments\" educates and empowers women in midlife to speak up for themselves and celebrate this natural change in their lives.\nNORTHBROOK, Ill., Dec. 5, 2024 /PRNewswire/ -- Astellas Pharma US, Inc. (TSE: 4503, Head of US Commercial: Michael Petroutsas, \"Astellas\") today announced the launch of Cooler Moments in partnership with Dr. Jen Ashton, a leading women's health medical expert, Founder and President of Ajenda, and former network news Chief Medical Correspondent who is board-certified in OBGYN and Obesity Medicine. Cooler Moments is an effort to inform and empower women to speak up about their moderate to severe menopausal hot flashes and night sweats, also known as vasomotor symptoms (VMS), and talk to their doctor about potential treatment options.1\nExperience the full interactive Multichannel News Release here:https://www.multivu.com/astellas_pharma/9261451-en-astellas-jen-ashton-launch-cooler-moments-spotlight-menopausal-hot-flashes \n\nThis effort shines light on the millions of women in the U.S. experiencing moderate to severe hot flashes and night sweats due to menopause, which can be very disruptive to daily life, with effects on sleep, mood, concentration, work productivity and relationships, among other things.1,2 Cooler Moments aims to inspire women to feel educated, empowered and confident to talk about this phase of life and advocate for themselves so that their symptoms can be addressed.\nAs part of Cooler Moments, Dr. Ashton will host a video series and speak to women live to debunk myths about menopause, break down the science, and encourage them to advocate for themselves when it comes to hot flashes and night sweats due to menopause. She will also speak with Kris, a woman with moderate to severe hot flashes and night sweats, about her personal experience and how she was able to manage her symptoms with VEOZAH™.3 VEOZAH is a first-of-its-kind, FDA-approved, 100% hormone-free treatment used to reduce moderate to severe hot flashes and night sweats due to menopause.3,4\nDo not use VEOZAH if you have cirrhosis, have severe kidney problems or kidney failure, or are taking certain medicines called CYP1A2 inhibitors.3 Please see additional Important Safety Information below.\nDr. Jen Ashton, Board-Certified OBGYN, Former Chief Medical Correspondent\"I'm honored to partner with Astellas to help inspire conversation about hot flashes and night sweats due to menopause and treatment options. Managing these symptoms is not one-size-fits-all, and women should feel comfortable having an open dialogue with their healthcare providers to create a plan that's right for them. As a doctor, I've seen how hot flashes due to menopause can significantly impact women, and I know how important it is women are counseled about all of their options, both hormonal and nonhormonal.2 Many women and doctors alike may not know that there are nonhormonal treatment options such as VEOZAH available, especially for women who cannot or choose not to take hormones.3 We are at a pivotal time to elevate cultural and medical conversations around hot flashes, night sweats, and menopause in a way that is backed in science and informed by the latest data, and to do so without judgment, fear or stigma.\"\nBen Ormsbee, U.S. Head of Commercial, Women's Health, Astellas\"Astellas is committed to elevating the conversation around hot flashes and night sweats due to menopause to help ensure women are informed and empowered to seek the support they need to make the best decision for their menopause journey. We're thrilled to launch Cooler Moments with Dr. Ashton, a leading women's health expert, to encourage women to not settle and to advocate for their own health.\"\nCooler Moments builds on the work that Astellas launched earlier this year with Emmy- and Golden Globe-nominated actress Gloria Reuben, who has experienced moderate to severe VMS due to menopause first-hand and has had fewer and less severe hot flashes and night sweats thanks to VEOZAH.3 Individual results may vary. Women should talk to their doctor about what it could mean to them.\nVisit VEOZAH.com for more information about moderate to severe VMS due to menopause, including Gloria Reuben's personal journey with VMS due to menopause, tips for how to have an informed conversation with your healthcare provider, and all there is to know about VEOZAH.\nAbout VEOZAH (fezolinetant)VEOZAH (fezolinetant) is a neurokinin 3 (NK3) receptor antagonist approved in the U.S. for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause.3 VEOZAH is not a hormone.3 VMS are the feelings of warmth in the face, neck, and chest, or sudden intense feelings of heat and sweating (\"hot flashes\" or \"hot flushes\").1 VEOZAH works by blocking neurokinin B (NKB) binding on the kisspeptin/neurokinin B/dynorphin (KNDy) neuron to modulate neuronal activity in the thermoregulatory center of the brain (the hypothalamus) to reduce the frequency and severity of moderate to severe VMS due to menopause.3\nAbout Vasomotor Symptoms due to MenopauseVMS, characterized by hot flashes (also called hot flushes) and/or night sweats, are common symptoms of menopause.1 In the U.S., nearly half of women going through menopause may experience moderate to severe VMS.5 VMS can have a disruptive impact on women's daily activities and overall quality of life.2\nU.S. Important Safety Information\nDo not use VEOZAH if you:\n\nhave cirrhosis.\nhave severe kidney problems or kidney failure.\nare taking certain medicines called CYP1A2 inhibitors. Ask your healthcare provider if you are not sure.\n\nBefore you use VEOZAH, tell your healthcare provider about all of your medical conditions, including if you:\n\nhave liver disease or problems.\nhave kidney problems.\nhave any medical conditions that may become worse while you are using VEOZAH.\n\nTell your healthcare provider about all the medicines you take, including prescription and over-the- counter medicines, vitamins, and herbal supplements. VEOZAH may affect the way other medicines work, and other medicines may affect how VEOZAH works.\nVEOZAH can cause serious side effects, including:\n\nincreased liver blood test values and liver problems. Your healthcare provider will do a blood test to check your liver before you start taking VEOZAH. Your healthcare provider will also do this blood test monthly for the first 3 months, at month 6, and month 9 after you start taking VEOZAH or if you have signs or symptoms that suggest liver problems. If your liver blood test values are elevated, your healthcare provider may advise you to stop treatment or request additional liver blood tests.\n\nStop VEOZAH and call your healthcare provider right away if you have the following signs or symptoms of liver problems:\n\nfeeling more tired than you do usually\nnausea\nvomiting\nitching\nyellowing of the eyes or skin (jaundice)\npale feces\ndark urine\npain in the right upper stomach (abdomen)\n\nThe most common side effects of VEOZAH include:\n\nstomach (abdominal) pain\ndiarrhea\ndifficulty sleeping (insomnia)\nback pain\nhot flashes or hot flushes\n\nThese are not all the possible side effects of VEOZAH. Tell your healthcare provider if you have any side effect that bothers you or does not go away.\nCall your healthcare provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800- FDA-1088.\nFor more information, please see the full Prescribing Information and Patient Product Information for VEOZAH (fezolinetant).\nAbout AstellasAstellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach that is designed to identify opportunities for the continuous creation of new drugs to address diseases with high unmet medical needs by focusing on Biology and Modality. Furthermore, we are also looking beyond our foundational Rx focus to create Rx+® healthcare solutions that combine our expertise and knowledge with cutting-edge technology in different fields of external partners. Through these efforts, Astellas stands on the forefront of healthcare change to turn innovative science into VALUE for patients. For more information, please visit our website at https://www.astellas.com/en.\nCautionary NotesIn this press release, statements made with respect to current plans, estimates, strategies and beliefs and other statements that are not historical facts are forward-looking statements about the future performance of Astellas. These statements are based on management's current assumptions and beliefs in light of the information currently available to it and involve known and unknown risks and uncertainties. A number of factors could cause actual results to differ materially from those discussed in the forward-looking statements. Such factors include, but are not limited to: (i) changes in general economic conditions and in laws and regulations, relating to pharmaceutical markets, (ii) currency exchange rate fluctuations, (iii) delays in new product launches, (iv) the inability of Astellas to market existing and new products effectively, (v) the inability of Astellas to continue to effectively research and develop products accepted by customers in highly competitive markets, and (vi) infringements of Astellas' intellectual property rights by third parties. Information about pharmaceutical products (including products currently in development) which is included in this press release is not intended to constitute an advertisement or medical advice.\nReferences:\n1 Thurston RC. Vasomotor symptoms. In: Crandall CJ, Bachman GA, Faubion SS, et al., eds. Menopause Practice: A Clinician's Guide. 6th ed. Pepper Pike, OH: The North American Menopause Society, 2019:43-55.2 English M, Stoykova B, Slota C, et al. Qualitative study: burden of menopause-associated vasomotor symptoms (VMS) and validation of PROMIS sleep disturbance and sleep-related impairment measures for assessment of VMS impact on sleep. J Patient Rep Outcomes 2021;5(37):1-13. Erratum in: J Patient Rep Outcomes 2021;5:423 Veozah [package insert]. Northbrook, IL: Astellas Pharma US, Inc.4 The North American Menopause Society. The 2023 nonhormone therapy position statement of the North American Menopause Society. Menopause. 2023;30(6):573-590.5 FFreeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause. 2014;21(9):924-932.\n\n\n\n View original content:https://www.prnewswire.com/news-releases/astellas-and-dr-jen-ashton-launch-cooler-moments-to-spotlight-menopausal-hot-flashes-and-empower-women-to-advocate-for-themselves-302323882.html\nSOURCE Astellas Pharma Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}